期刊文献+

肝癌组织中CLDN1的表达及其过表达对肝癌细胞恶性表型的影响 被引量:2

The expression of CLDN1 in liver cancer tissues and the effect of CLDN1 overexpression on the malignant phentype of liver cancer cells
下载PDF
导出
摘要 目的:探讨CLDN1在肝癌组织中的表达及其过表达对肝癌细胞恶性表型的影响。方法:通过免疫组化法及PCR法测定肝癌组织与癌旁组织中CLDN表达水平,建立CLDN1过表达细胞系,测定CLDN1过表达细胞株增殖能力、肿瘤细胞成球能力及干性相关标志物水平。结果:CLDN1在肝癌组织中表达阳性率为65.2%(58/89),在癌旁组织中表达阳性率为25.5%(14/55),差异具有统计学意义(P<0.001);CLDN1过表达肝癌细胞株增殖能力、肿瘤细胞成球能力均明显增强,并且肿瘤干性相关分子标志物水平明显提高。结论:CLDN1过表达可影响肝癌细胞干性获得,提示CLDN1表达水平与肝癌发生发展密切相关。 Objective:To explore the expression of CLDN1 in hepatocellular carcinoma,and to explore the effect of CLDN1 overexpression on the malignant phenotype of liver cancer cells.Methods:The expression levels of CLDN in liver cancer tissues and adjacent tissues were determined by immunohistochemistry and PCR methods,and the CLDN1 overexpression cell line was established.The proliferation ability of CLDN1 overexpression cell lines,tumor cell sphere formation ability and stem-related markers were determined.Results:The positive rate of CLDN1 expression in liver cancer tissues was 65.2%(58/89),and the positive rate in adjacent tissues was 25.5%(14/55),the difference was statistically significant(P<0.001).CLDN1 overexpression of hepatocellular carcinoma cell line proliferative ability,tumor cell sphere formation ability were significantly enhanced,and tumor stem related molecular markers were significantly increased.Conclusion:The overexpression of CLDN1 can affect the dryness of liver cancer cells,suggesting that the expression level of CLDN1 is closely related to the occurrence and development of liver cancer.
作者 沙娅·玛哈提 迪娜·艾尼瓦尔 肖蕾 张华 Shaya·Mahati;Dina·Ainiwaer;XIAO Lei;ZHANG Hua(First Affiliated Hospital of Xinjiang Medical University,Xinjiang Urumqi 830054,China.)
出处 《现代肿瘤医学》 CAS 北大核心 2021年第13期2230-2234,共5页 Journal of Modern Oncology
基金 吴阶平医学基金会临床科研专项资助基金(编号:320.6750.19088-64)。
关键词 肝细胞肝癌 CLDN1 临床特征 细胞干性 hepatocellular carcinoma(HCC) CLDN1 clinical features stem cell traits
  • 相关文献

参考文献8

二级参考文献83

  • 1黎乐群.原发性肝癌的规范化综合治疗[J].广西医学,2004,26(9):1241-1243. 被引量:3
  • 2Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, et al. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Ann Thorac Surg 2006; 81: 292-297.
  • 3Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest 1991; 100: 422-428.
  • 4Buonomo T, Carraresi L, Rossini M, Martinelli R. Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins. J Transl Med 2011 ; 9: 2.
  • 5Jiang R, Jin Z, Liu Z, Sun L, Wang L, Li K. Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma. Mol Diagn Ther 2011; 15: 347-352.
  • 6Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185- 193.
  • 7Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20.
  • 8Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2001; 2: 21-32.
  • 9van Roozendaal CE, Gillis A J, Klijn JG, van Ooijen B, Claassen C J, Eggermont AM, et al. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Lett 1998; 437: 107-111.
  • 10Kim KS, Lee YI. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett 1997; 119: 143- 148.

共引文献53

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部